Previously, we identified plasma microRNA (miR) profiles that associate with markers of
microvascular injury in patients with diabetic nephropathy (DN). However, miRs circulate in …

Rationale: MicroRNAs (miRNAs) have been implicated in the epigenetic regulation of key
metabolic, inflammatory, and antiangiogenic pathways in type 2 diabetes (DM) and may …

Aims Chronic kidney disease (CKD) is an independent risk factor for the development of
coronary artery disease (CAD). For both, CKD and CAD, the intercellular transfer of …

Objective MicroRNAs (miRNAs) have emerged as promising regulators of diabetes mellitus
(DM)-induced angiogenic dysfunction in endothelial cells (ECs), but information vis-à-vis the …

Aim Microangiopathy due to endothelial dysfunction is a major contributing factor to the
development of diabetes-induced cardiovascular disease (CVD). Dysregulation of …

Because microvascular disease is one of the most important drivers of diabetic
complications, early monitoring of microvascular integrity may be of clinical value. By …

Circulating microRNAs (miRNAs) have emerged as novel biomarkers of diabetes. The
current study focuses on the role of circulating miRNAs in patients with type 1 diabetes and …

Abstract Background Circulating microRNAs (miRs) are differentially regulated and
selectively packaged into microparticles (MPs). We evaluated whether diabetes mellitus …

Background—Diabetes mellitus impairs endothelial cell (EC) function and postischemic
reparative neovascularization by molecular mechanisms that are not fully understood …

Background MicroRNAs have been demonstrated to play an important role in the
pathogenesis of diabetic nephropathy (DN). In this study, we investigated both the repertoire …